Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» LY3819469
LY3819469
Eli Lilly Collab Scores IND Approval for Dicerna's RNAi Cardiometabolic Drug
BioSpace
Thu, 05/27/21 - 11:09 am
Dicerna
Eli Lilly
LY3819469
clinical trials
RNAi
cardiometabolic diseases